vs
CADIZ INC（CDZI）与Immunovant, Inc.（IMVT）财务数据对比。点击上方公司名可切换其他公司
Immunovant, Inc.的季度营收约是CADIZ INC的1.6倍（$8.4M vs $5.1M），Immunovant, Inc.同比增速更快（140.7% vs 7.0%），CADIZ INC自由现金流更多（$-8.2M vs $-59.8M）
Cadiz Inc是一家总部位于美国的自然资源与可持续发展企业，核心业务包括水资源管理、农业用地运营及可再生能源项目开发，主要在加利福尼亚州开展业务，为市政、农业及商业客户提供稳定的供水解决方案与土地管护服务。
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
CDZI vs IMVT — 直观对比
营收规模更大
IMVT
是对方的1.6倍
$5.1M
营收增速更快
IMVT
高出133.7%
7.0%
自由现金流更多
CDZI
多$51.6M
$-59.8M
损益表 — Q4 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $5.1M | $8.4M |
| 净利润 | — | $-75.3M |
| 毛利率 | 33.0% | — |
| 营业利润率 | -145.4% | -896.2% |
| 净利率 | — | -899.0% |
| 营收同比 | 7.0% | 140.7% |
| 净利润同比 | — | -26.7% |
| 每股收益（稀释后） | — | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDZIIMVT
| Q4 25 | $5.1M | — | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $4.1M | — | ||
| Q1 25 | $3.0M | — | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $513.0K | — | ||
| Q1 24 | $1.1M | $8.4M |
净利润CDZIIMVT
| Q4 25 | — | — | ||
| Q3 25 | $-7.1M | — | ||
| Q2 25 | $-7.7M | — | ||
| Q1 25 | $-9.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.8M | — | ||
| Q2 24 | $-8.9M | — | ||
| Q1 24 | $-6.8M | $-75.3M |
毛利率CDZIIMVT
| Q4 25 | 33.0% | — | ||
| Q3 25 | 27.3% | — | ||
| Q2 25 | 35.4% | — | ||
| Q1 25 | 29.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.4% | — |
营业利润率CDZIIMVT
| Q4 25 | -145.4% | — | ||
| Q3 25 | -118.0% | — | ||
| Q2 25 | -140.0% | — | ||
| Q1 25 | -255.0% | — | ||
| Q4 24 | -139.5% | — | ||
| Q3 24 | -147.9% | — | ||
| Q2 24 | -1354.6% | — | ||
| Q1 24 | -437.8% | -896.2% |
净利率CDZIIMVT
| Q4 25 | — | — | ||
| Q3 25 | -170.5% | — | ||
| Q2 25 | -187.3% | — | ||
| Q1 25 | -324.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -210.7% | — | ||
| Q2 24 | -1729.4% | — | ||
| Q1 24 | -611.1% | -899.0% |
每股收益（稀释后）CDZIIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.6M | $635.4M |
| 总债务越低越好 | $72.7M | — |
| 股东权益账面价值 | $23.3M | $617.8M |
| 总资产 | $140.9M | $666.4M |
| 负债/权益比越低杠杆越低 | 3.13× | — |
8季度趋势，按日历期对齐
现金及短期投资CDZIIMVT
| Q4 25 | $8.6M | — | ||
| Q3 25 | $4.4M | — | ||
| Q2 25 | $13.2M | — | ||
| Q1 25 | $21.6M | — | ||
| Q4 24 | $17.3M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $19.2M | $635.4M |
总债务CDZIIMVT
| Q4 25 | $72.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $56.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CDZIIMVT
| Q4 25 | $23.3M | — | ||
| Q3 25 | $27.7M | — | ||
| Q2 25 | $35.6M | — | ||
| Q1 25 | $44.0M | — | ||
| Q4 24 | $34.0M | — | ||
| Q3 24 | $20.7M | — | ||
| Q2 24 | $27.6M | — | ||
| Q1 24 | $36.6M | $617.8M |
总资产CDZIIMVT
| Q4 25 | $140.9M | — | ||
| Q3 25 | $128.0M | — | ||
| Q2 25 | $136.4M | — | ||
| Q1 25 | $145.6M | — | ||
| Q4 24 | $134.5M | — | ||
| Q3 24 | $112.6M | — | ||
| Q2 24 | $118.1M | — | ||
| Q1 24 | $118.1M | $666.4M |
负债/权益比CDZIIMVT
| Q4 25 | 3.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.67× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $-59.7M |
| 自由现金流经营现金流 - 资本支出 | $-8.2M | $-59.8M |
| 自由现金流率自由现金流/营收 | -162.2% | -714.4% |
| 资本支出强度资本支出/营收 | 26.1% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-26.5M | $-214.6M |
8季度趋势，按日历期对齐
经营现金流CDZIIMVT
| Q4 25 | $-6.9M | — | ||
| Q3 25 | $-7.0M | — | ||
| Q2 25 | $-1.4M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-6.2M | — | ||
| Q3 24 | $-5.4M | — | ||
| Q2 24 | $-7.1M | — | ||
| Q1 24 | $-2.9M | $-59.7M |
自由现金流CDZIIMVT
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-7.5M | — | ||
| Q2 25 | $-5.9M | — | ||
| Q1 25 | $-4.9M | — | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-5.4M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $-3.1M | $-59.8M |
自由现金流率CDZIIMVT
| Q4 25 | -162.2% | — | ||
| Q3 25 | -179.8% | — | ||
| Q2 25 | -142.2% | — | ||
| Q1 25 | -167.0% | — | ||
| Q4 24 | -139.4% | — | ||
| Q3 24 | -168.8% | — | ||
| Q2 24 | -1431.6% | — | ||
| Q1 24 | -272.9% | -714.4% |
资本支出强度CDZIIMVT
| Q4 25 | 26.1% | — | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 109.3% | — | ||
| Q1 25 | 43.6% | — | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 54.8% | — | ||
| Q1 24 | 16.6% | 1.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDZI
| Water Treatment | $4.4M | 86% |
| Other | $724.0K | 14% |
IMVT
暂无分部数据
